Clinical Lab Automation Market to be Worth $4.01 Billion by 2031

Next-generation sequencing (NGS) technology has significantly reduced DNA sequencing costs. Moreover, it has revolutionized the field of genetic disease diagnostics with rapid, high-throughput, and cost-effective approaches. NGS can simultaneously analyze hundreds of genes, the whole exome, and the whole genome, enabling researchers to gain a deeper understanding of unknown species and complex diseases.